We demonstrated that CD8+ T cells coexpressing CD39 and CD103 accumulate in the central parts of the tumor, present an exhausted phenotype with high expression of immune checkpoint markers, and display a distinct chemokine receptor expression pattern. This evidence concerns the gene ENTPD1 and neoplasm.